Skip to content
COVID-19 / SPECIALTY RESEARCH

EpidemiologyIn perspective.

The key COVID-19 findings in epidemiology, distilled into a clear, readable brief. The evidence is here whenever you want to go deeper.

INSIDE THIS MONITOR
36cited sources
16available findings

Study findings updated

AI-assisted evidence summary. For general information. These findings are not individual medical advice or a clinician endorsement.

THE SHORT VERSION

What’s worth knowing.

The key findings, what they mean, and the context that matters.

THE HEADLINE TAKEAWAY6.2%

Long COVID clusters occurred in an estimated 6.2% of symptomatic individuals

Globally, an estimated 6.2% of symptomatic individuals developed the studied Long COVID symptom clusters.

This estimate applies to the studied persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021; the 95% uncertainty interval was 2.4-13.3%.

See the evidence

of symptomatic individuals develop Long COVID symptom clusters

6.2%

Global Burden of Disease Long COVID Collaborators. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604-1615.

02

Socioeconomic infection gaps narrowed during Omicron but persisted

In Canada, the estimated infection rate among susceptible people was higher in the most materially deprived quintile than in the least materially deprived quintile: the ratio was 1.71 before Omicron and 1.12 during Omicron.

The relative gradient compressed during Omicron; the larger rise in the least-deprived group reflected its lower pre-Omicron baseline. Study design is not available in this summary.

See the evidence

Pre-Omicron force of infection in the most materially deprived quintile compared with the least deprived quintile

IRR 1.71
95% CI: 1.60-1.83

Hassan, Abdullah et al.. Seroprevalence convergence masks persistent socioeconomic disparities in SARS-CoV-2 infection risk in Canada.. Epidemics. 2026.

Added

Omicron-related relative increase in force of infection in the least-deprived versus most-deprived quintiles; the larger increase in the least-deprived group reflected its lower pre-Omicron baseline

48.5-fold vs 31.8-fold

Hassan, Abdullah et al.. Seroprevalence convergence masks persistent socioeconomic disparities in SARS-CoV-2 infection risk in Canada.. Epidemics. 2026.

Added

Omicron-period force of infection in the most materially deprived quintile compared with the least deprived quintile, after compression of the relative socioeconomic gradient

IRR 1.12
95% CI: 1.11-1.14

Hassan, Abdullah et al.. Seroprevalence convergence masks persistent socioeconomic disparities in SARS-CoV-2 infection risk in Canada.. Epidemics. 2026.

Added

03

Full vaccination was linked to lower infection odds in prisoners

62%lower relative odds

In a systematic review and meta-analysis, fully vaccinated prisoners had 62% lower relative odds of COVID-19 infection than unvaccinated prisoners.

This is a relative odds estimate, not an absolute risk difference. The component study designs and follow-up are not available in this summary.

See the evidence

62% lower relative odds, calculated from OR 0.38. This is not an absolute percentage-point difference.

Odds of COVID-19 infection among fully vaccinated prisoners compared with unvaccinated prisoners

OR 0.38
95% CI: 0.22-0.67

SeyedAlinaghi, SeyedAhmad et al.. Risk Factors of the Spread of COVID-19 in Prisoners: A Systematic Review and Meta-Analysis.. Disaster medicine and public health preparedness. 2026.

Added

04

A U.S. review quantified weekly nursing-home COVID-19 burden

38-71 per 1,000 residents weekly

The review reported weekly hospitalization rates of 38-71 per 1,000 nursing-home residents and infection incidence of 614-1338 per 1,000 residents.

All included studies covered Omicron-period data, although most also covered earlier variant periods; the ranges should not be treated as Omicron-only.

See the evidence

Weekly COVID-19 hospitalization rates among US nursing home residents; all studies included Omicron-period data, although most also included earlier variant periods

38-71 per 1,000 residents weekly

Gravenstein, Stefan et al.. Current Impact of COVID-19 in Long-Term Care Facilities in the United States: A Systematic Literature Review.. The Senior care pharmacist. 2026.

Added

Weekly COVID-19 infection incidence among US nursing home residents; all studies included Omicron-period data, although most also included earlier variant periods

614-1338 per 1,000 residents weekly

Gravenstein, Stefan et al.. Current Impact of COVID-19 in Long-Term Care Facilities in the United States: A Systematic Literature Review.. The Senior care pharmacist. 2026.

Added

05

Modeled estimates of U.S. health loss from COVID-19

9,242,000 QALYs lost

A model estimated 9,242,000 quality-adjusted life-years lost in the United States to fatal and nonfatal COVID-19 outcomes from July 2020 through December 2022.

The same source separately estimated approximately 865,000 quality-adjusted life-years lost annually to Long COVID. Both figures are modeled population estimates.

See the evidence

Modeled cumulative US QALY loss attributable to fatal and nonfatal COVID-19 outcomes from July 2020 through December 2022

9,242,000 QALYs lost
95% UI: 7,808,000-11,311,000

Mikdashi, Fatima et al.. Estimating the Quality-Adjusted Life-Year Loss due to Fatal and Nonfatal COVID-19 Outcomes across US States and Counties, July 2020 to December 2022.. MDM policy & practice. 2026.

Added

Modeled annual QALY loss attributable to Long COVID in the United States

Approximately 865,000 QALYs lost annually
95% UI: 355,000-1,591,000

Mikdashi, Fatima et al.. Estimating the Quality-Adjusted Life-Year Loss due to Fatal and Nonfatal COVID-19 Outcomes across US States and Counties, July 2020 to December 2022.. MDM policy & practice. 2026.

Added

Study-specific findings. Different populations, treatments and follow-up periods can produce different results.

THE RESEARCH, AS IT ARRIVES

Latest studies.

The newest findings added to this collection.
The learning from each, already distilled.

  1. STUDY 01Findings added
    TL;DR

    More colleague connections tracked earlier Omicron onset

    3.7 days earlier per two-fold increase

    A two-fold increase in within-province colleague connections was associated with Omicron onset 3.7 days earlier.

    Registry-based spatial mapping; the reported 95% interval was 0.6 to 6.6 days, and the association does not establish causation. Regional mobility restrictions targeting Zeeland or Amsterdam were estimated to remove 2.6% or 10.0% of national colleague links, respectively.

    Study details & original results

    Song, PingPing et al.. Mapping spatial colleague connectivity patterns from individual-level registry data to inform regional pandemic interventions.. PLoS computational biology. 2026.

    Association between a two-fold increase in within-province colleague connections and earlier Omicron onset

    3.7 days earlier per two-fold increase
    95% CI: 0.6 to 6.6 days

    Estimated share of national colleague links removed by regional mobility restrictions targeting Zeeland province or Amsterdam

    2.6% for Zeeland; 10.0% for Amsterdam

    Citation in Epidemiology
  2. STUDY 02Findings added
    TL;DR

    A U.S. review quantified weekly nursing-home COVID-19 burden

    38-71 per 1,000 residents weekly

    The review reported weekly hospitalization rates of 38-71 per 1,000 nursing-home residents and infection incidence of 614-1338 per 1,000 residents.

    All included studies covered Omicron-period data, although most also covered earlier variant periods; the ranges should not be treated as Omicron-only.

    Study details & original results

    Gravenstein, Stefan et al.. Current Impact of COVID-19 in Long-Term Care Facilities in the United States: A Systematic Literature Review.. The Senior care pharmacist. 2026.

    Weekly COVID-19 hospitalization rates among US nursing home residents; all studies included Omicron-period data, although most also included earlier variant periods

    38-71 per 1,000 residents weekly

    Weekly COVID-19 infection incidence among US nursing home residents; all studies included Omicron-period data, although most also included earlier variant periods

    614-1338 per 1,000 residents weekly

    Citation in Epidemiology
  3. STUDY 03Findings added
    TL;DR

    Socioeconomic infection gaps narrowed during Omicron but persisted

    In Canada, the estimated infection rate among susceptible people was higher in the most materially deprived quintile than in the least materially deprived quintile: the ratio was 1.71 before Omicron and 1.12 during Omicron.

    The relative gradient compressed during Omicron; the larger rise in the least-deprived group reflected its lower pre-Omicron baseline. Study design is not available in this summary.

    Study details & original results

    Hassan, Abdullah et al.. Seroprevalence convergence masks persistent socioeconomic disparities in SARS-CoV-2 infection risk in Canada.. Epidemics. 2026.

    Pre-Omicron force of infection in the most materially deprived quintile compared with the least deprived quintile

    IRR 1.71
    95% CI: 1.60-1.83

    Omicron-related relative increase in force of infection in the least-deprived versus most-deprived quintiles; the larger increase in the least-deprived group reflected its lower pre-Omicron baseline

    48.5-fold vs 31.8-fold

    Omicron-period force of infection in the most materially deprived quintile compared with the least deprived quintile, after compression of the relative socioeconomic gradient

    IRR 1.12
    95% CI: 1.11-1.14

    Citation in Epidemiology
  4. STUDY 04Findings added
    TL;DR

    Full vaccination was linked to lower infection odds in prisoners

    62%lower relative odds

    In a systematic review and meta-analysis, fully vaccinated prisoners had 62% lower relative odds of COVID-19 infection than unvaccinated prisoners.

    This is a relative odds estimate, not an absolute risk difference. The component study designs and follow-up are not available in this summary.

    Study details & original results

    SeyedAlinaghi, SeyedAhmad et al.. Risk Factors of the Spread of COVID-19 in Prisoners: A Systematic Review and Meta-Analysis.. Disaster medicine and public health preparedness. 2026.

    Odds of COVID-19 infection among fully vaccinated prisoners compared with unvaccinated prisoners

    OR 0.38
    95% CI: 0.22-0.67

    62% lower relative odds, calculated from OR 0.38. This is not an absolute percentage-point difference.

    Citation in Epidemiology
4 of 5 study updates

Dates show when findings were added here, not when papers were published. Study populations and comparisons differ.

WHEN YOU WANT TO GO DEEPER
See all 16 findingsOriginal results, comparisons and study details.
7 of 7 source groupsFindings stay together with their study.
SOURCE 362 findings

Song, PingPing et al.. Mapping spatial colleague connectivity patterns from individual-level registry data to inform regional pandemic interventions.. PLoS computational biology. 2026.

Association between a two-fold increase in within-province colleague connections and earlier Omicron onset

Added
3.7 days earlier per two-fold increase95% CI: 0.6 to 6.6 daysSource [36]

Estimated share of national colleague links removed by regional mobility restrictions targeting Zeeland province or Amsterdam

Added
2.6% for Zeeland; 10.0% for AmsterdamSource [36]
SOURCE 352 findings

Gravenstein, Stefan et al.. Current Impact of COVID-19 in Long-Term Care Facilities in the United States: A Systematic Literature Review.. The Senior care pharmacist. 2026.

Weekly COVID-19 infection incidence among US nursing home residents; all studies included Omicron-period data, although most also included earlier variant periods

Added
614-1338 per 1,000 residents weeklySource [35]

Weekly COVID-19 hospitalization rates among US nursing home residents; all studies included Omicron-period data, although most also included earlier variant periods

Added
38-71 per 1,000 residents weeklySource [35]
SOURCE 343 findings

Hassan, Abdullah et al.. Seroprevalence convergence masks persistent socioeconomic disparities in SARS-CoV-2 infection risk in Canada.. Epidemics. 2026.

Pre-Omicron force of infection in the most materially deprived quintile compared with the least deprived quintile

Added
IRR 1.7195% CI: 1.60-1.83Source [34]

Omicron-period force of infection in the most materially deprived quintile compared with the least deprived quintile, after compression of the relative socioeconomic gradient

Added
IRR 1.1295% CI: 1.11-1.14Source [34]
All 3 findings from this source

Omicron-related relative increase in force of infection in the least-deprived versus most-deprived quintiles; the larger increase in the least-deprived group reflected its lower pre-Omicron baseline

Added
48.5-fold vs 31.8-foldSource [34]
SOURCE 331 finding

SeyedAlinaghi, SeyedAhmad et al.. Risk Factors of the Spread of COVID-19 in Prisoners: A Systematic Review and Meta-Analysis.. Disaster medicine and public health preparedness. 2026.

Odds of COVID-19 infection among fully vaccinated prisoners compared with unvaccinated prisoners

Added
OR 0.3895% CI: 0.22-0.67Source [33]
SOURCE 322 findings

Mikdashi, Fatima et al.. Estimating the Quality-Adjusted Life-Year Loss due to Fatal and Nonfatal COVID-19 Outcomes across US States and Counties, July 2020 to December 2022.. MDM policy & practice. 2026.

Modeled cumulative US QALY loss attributable to fatal and nonfatal COVID-19 outcomes from July 2020 through December 2022

Added
9,242,000 QALYs lost95% UI: 7,808,000-11,311,000Source [32]

Modeled annual QALY loss attributable to Long COVID in the United States

Added
Approximately 865,000 QALYs lost annually95% UI: 355,000-1,591,000Source [32]
SOURCE 315 findings

Parker, Edward P K et al.. Factors associated with severe COVID-19 in immunocompromised subgroups in England from 2020 to 2024: an OpenSAFELY cohort study.. EBioMedicine. 2026.

Vaccine protection against severe COVID-19 in solid organ transplant recipients during JN.1 wave

HR 0.8895% CI 0.60-1.30Source [31]

Vaccine protection against severe COVID-19 in bone marrow compromise patients during JN.1 wave

HR 0.6495% CI 0.53-0.77Source [31]
All 5 findings from this source

Vaccine protection against severe COVID-19 in active radio- or chemo-therapy patients during JN.1 wave

HR 0.6895% CI 0.44-1.03Source [31]

Vaccine protection against severe COVID-19 in active immunosuppressive medication patients during JN.1 wave

HR 0.6895% CI 0.52-0.88Source [31]

Vaccine protection against severe COVID-19 in primary or acquired immunodeficiency patients during JN.1 wave

HR 0.6895% CI 0.55-0.82Source [31]
Browse the 36 original sourcesThe complete bibliography behind this monitor.
  1. [1]

    Lopez-Leon S, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Scientific Reports. 2021;11:16144.

    Open original source in a new tab
  2. [2]

    Chen C, et al. Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review. Journal of Infectious Diseases. 2022;226(9):1593-1607.

    Open original source in a new tab
  3. [3]

    Notarte KI, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine. 2022;53:101624.

    Open original source in a new tab
  4. [4]

    Global Burden of Disease Long COVID Collaborators. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604-1615.

    Open original source in a new tab
  5. [5]

    Ceban F, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain, Behavior, and Immunity. 2022;101:93-135.

    Open original source in a new tab
  6. [6]

    Xie Y, et al. Long-term cardiovascular outcomes of COVID-19. Nature Medicine. 2022;28:583-590.

    Open original source in a new tab
  7. [7]

    Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes & Endocrinology. 2022;10(5):311-321.

    Open original source in a new tab
  8. [8]

    Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nature Medicine. 2022;28:2398-2405.

    Open original source in a new tab
  9. [9]

    Huang C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220-232.

    Open original source in a new tab
  10. [10]

    Huang L, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747-758.

    Open original source in a new tab
  11. [11]

    PHOSP-COVID Collaborative Group. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK. Lancet Respiratory Medicine. 2022;10(8):761-775.

    Open original source in a new tab
  12. [12]

    Ballering AV, et al. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400(10350):452-461.

    Open original source in a new tab
  13. [13]

    Douaud G, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697-707.

    Open original source in a new tab
  14. [14]

    Hampshire A, et al. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39:101044.

    Open original source in a new tab
  15. [15]

    Taquet M, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies. Lancet Psychiatry. 2022;9(10):815-827.

    Open original source in a new tab
  16. [16]

    Swank Z, et al. Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 Sequelae. Clinical Infectious Diseases. 2023;76(3):e487-e490.

    Open original source in a new tab
  17. [17]

    Su Y, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881-895.e20.

    Open original source in a new tab
  18. [18]

    Peluso MJ, et al. Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of SARS-CoV-2 Infection. Journal of Infectious Diseases. 2021;224(11):1839-1848.

    Open original source in a new tab
  19. [19]

    Watanabe A, et al. Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years. JAMA Pediatrics. 2023;177(4):384-394.

    Open original source in a new tab
  20. [20]

    Xie Y, et al. Nirmatrelvir and the Risk of Post-Acute Sequelae of COVID-19. JAMA Internal Medicine. 2023;183(6):554-564.

    Open original source in a new tab
  21. [21]

    Hammond J, et al. Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19. New England Journal of Medicine. 2022;386:1397-1408.

    Open original source in a new tab
  22. [22]

    Sudre CH, et al. Attributes and predictors of long COVID. Nature Medicine. 2021;27:626-631.

    Open original source in a new tab
  23. [23]

    Subramanian A, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nature Medicine. 2022;28:1706-1714.

    Open original source in a new tab
  24. [24]

    Thompson EJ, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nature Communications. 2022;13:3528.

    Open original source in a new tab
  25. [25]

    World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. October 2021.

    Original source link unavailable
  26. [26]

    National Institute for Health and Care Excellence (NICE). COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE guideline [NG188]. December 2020 (updated).

    Original source link unavailable
  27. [27]

    Centers for Disease Control and Prevention. Long COVID or Post-COVID Conditions. Updated 2023.

    Original source link unavailable
  28. [28]

    Levin AT, et al. Assessing the age specificity of infection fatality rates for COVID-19. European Journal of Epidemiology. 2020;35:1123-1138.

    Open original source in a new tab
  29. [29]

    Wang H, et al. Estimating excess mortality due to the COVID-19 pandemic. Lancet. 2022;399(10334):1513-1536.

    Open original source in a new tab
  30. [30]

    Nalbandian A, et al. Post-acute COVID-19 syndrome. Nature Medicine. 2021;27:601-615.

    Open original source in a new tab
  31. [31]

    Parker, Edward P K et al.. Factors associated with severe COVID-19 in immunocompromised subgroups in England from 2020 to 2024: an OpenSAFELY cohort study.. EBioMedicine. 2026.

    Open original source in a new tab
  32. [32]

    Mikdashi, Fatima et al.. Estimating the Quality-Adjusted Life-Year Loss due to Fatal and Nonfatal COVID-19 Outcomes across US States and Counties, July 2020 to December 2022.. MDM policy & practice. 2026.

    Open original source in a new tab
  33. [33]

    SeyedAlinaghi, SeyedAhmad et al.. Risk Factors of the Spread of COVID-19 in Prisoners: A Systematic Review and Meta-Analysis.. Disaster medicine and public health preparedness. 2026.

    Open original source in a new tab
  34. [34]

    Hassan, Abdullah et al.. Seroprevalence convergence masks persistent socioeconomic disparities in SARS-CoV-2 infection risk in Canada.. Epidemics. 2026.

    Open original source in a new tab
  35. [35]

    Gravenstein, Stefan et al.. Current Impact of COVID-19 in Long-Term Care Facilities in the United States: A Systematic Literature Review.. The Senior care pharmacist. 2026.

    Open original source in a new tab
  36. [36]

    Song, PingPing et al.. Mapping spatial colleague connectivity patterns from individual-level registry data to inform regional pandemic interventions.. PLoS computational biology. 2026.

    Open original source in a new tab
ABOUT THIS MONITOR

Understanding includes the limits.

This is an AI-assisted evidence summary, not a clinician endorsement. Read each original paper for its complete methods, population and limitations. Different studies can ask different questions and report different kinds of results.

Dates marked “added” describe when a finding entered this monitor, not when the study was published or clinically reviewed. Personal health and treatment decisions belong in a conversation with a qualified clinician.

KEEP YOUR QUESTIONS CLOSE

A little more understanding.
Wherever you are.

Explore the ModernDoc app